10532
D. J. Phillips et al. / Tetrahedron 63 (2007) 10528–10533
32.5, 32.3, 24.6, 14.7; MS (CI, NH3) m/z 190 (M+NH4)+,
173 (M+H)+; HRMS (CI, NH3) calculated for C9H17O3
(M+H)+ 173.1172; found (M+H)+ 173.1172.
168.3, 166.8, 147.8, 140.2, 129.4, 122.5, 60.9, 60.7, 31.4,
27.5, 14.6, 12.8; MS (CI, NH3) m/z 258 (M+NH4)+, 241
(M+H)+; HRMS (CI, NH3) calculated for C13H24O4N
(M+NH4)+ 258.1700; found (M+NH4)+ 258.1697.
4.2.6. E-7-Hydroxy-2-methyl-hept-2-enoic acid ethyl es-
ter (9). The title compound (163 mg, 52%) was obtained
as a colorless oil. IR nmax (film)/cmꢀ1 (neat) 3390, 1706,
1655, 1367, 1252, 1092; 1H NMR (400 MHz; CDCl3) 1.05
(3H, t, J¼7 Hz), 1.20 (1H, br s, OH), 1.25–1.45 (4H, m),
1.65 (3H, s), 1.95–2.15 (2H, m), 3.45 (2H, t, J¼7 Hz),
4.00 (2H, q, J¼7 Hz), 6.60 (1H, t, J¼7 Hz); 13C NMR
(100 MHz; CDCl3) d¼168.7, 142.2, 128.4, 63.0, 60.9,
32.7, 28.7, 25.2, 14.7, 12.8; MS (CI, NH3) m/z 204
(M+NH4)+, 187 (M+H)+; HRMS (CI, NH3) calculated for
C10H19O3 (M+H)+ 187.1329; found (M+H)+ 187.1328.
4.3.3. E,E-Octa-2,6-dienedioic acid ethyl methyl ester
(14). The title compound (167 mg, 65%) was obtained as
a colorless oil. IR nmax (film)/cmꢀ1 (neat) 2984, 1716,
1
1655, 1368, 1267, 1094; H NMR (400 MHz; CDCl3) 1.30
(3H, t, J¼7 Hz), 2.35–2.40 (4H, m), 3.75 (3H, s), 4.19
(2H, q, J¼7 Hz), 5.80–5.85 (2H, m), 6.90–7.00 (2H, m);
13C NMR (100 MHz; CDCl3) d¼167.2, 166.7, 147.6,
147.2, 122.8, 122.3, 60.7, 51.9, 30.9, 30.8, 14.6; MS (CI,
NH3) m/z 230 (M+NH4)+, 213 (M+H)+; HRMS (CI, NH3)
calculated for C11H20O4N (M+NH4)+ 230.1387; found
(M+NH4)+ 230.1388.
4.2.7. E-8-Hydroxy-oct-2-enoic acid ethyl ester (10). The
title compound (180 mg, 56%) was obtained as a colorless
oil. IR nmax (film)/cmꢀ1 (neat) 3425, 1717, 1652, 1266,
1182, 1095; 1H NMR (400 MHz; CDCl3) 1.31 (3H, t,
J¼7 Hz), 1.38–1.66 (7H, m), 2.24 (2H, m), 3.67 (2H, t,
J¼7 Hz), 4.20 (2H, q, J¼7 Hz), 5.84 (1H, dt, J¼16,
1.5 Hz), 6.98 (1H, dt, J¼16, 7 Hz); 13C NMR (100 MHz;
CDCl3) d¼167.2, 149.5, 121.8, 63.1, 60.6, 32.9, 32.5,
28.2, 25.7, 14.7; MS (CI, NH3) m/z 204 (M+NH4)+, 187
(M+H)+; HRMS (CI, NH3) calculated for C10H22O3N
(M+NH4)+ 204.1594; found (M+NH4)+ 204.1595.
4.3.4. E,E-2-Methyl-octa-2,6-dienedioic acid ethyl methyl
ester (15). The title compound (310 mg, 69%) was obtained
as a colorless oil. IR nmax (film)/cmꢀ1 (neat) 2982, 1707,
1
1652, 1367, 1260, 1094; H NMR (400 MHz; CDCl3) 1.21
(3H, t, J¼7 Hz), 1.74 (3H, d, J¼1 Hz), 2.27 (4H, m), 3.64
(3H, s), 4.10 (2H, q, J¼7 Hz), 5.77 (1H, dt, J¼16, 1 Hz),
6.60–6.65 (1H, m), 6.80–6.85 (1H, m); 13C NMR
(100 MHz; CDCl3) d¼168.3, 167.2, 148.1, 140.2, 129.4,
122.1, 60.9, 51.8, 31.4, 27.5, 14.6, 12.8; MS (CI, NH3) m/z
244 (M+NH4)+, 227 (M+H)+; HRMS (CI, NH3) calculated
for C12H22O4N (M+NH4)+ 244.1543; found (M+NH4)+
244.1453.
4.3. General procedure for the PCC-mediated synthesis
of dienyl diesters
4.3.5. E,E-Nona-2,7-dienedioic acid diethyl ester (16).
The title compound (87 mg, 74%) was obtained as a colorless
oil. IR nmax (film)/cmꢀ1 (neat) 2982, 1715, 1653, 1367,
4.3.1. E,E-Octa-2,6-dienedioic acid diethyl ester (12). A
mixture of E-6-hydroxy-hex-2-enoic acid ethyl ester
(167 mg, 1.06 mmol) 6 and pyridinium chlorochromate
(2 equiv, 0.46 g, 2.12 mmol, ground with 2 wt equiv of
silica, 0.92 g) was stirred for 4 h at room temperature in
dichloromethane (50 ml). Imidazole (2 equiv, 0.14 g,
2.12 mmol) was added and the reaction mixture stirred for
a further 1 h. The addition of (ethoxycarbonylmethylene)tri-
phenylphosphorane 2 (2.4 equiv, 0.88 g, 2.54 mmol) was
followed by 19 h of stirring. At this time the silica supported
pyridinium chlorochromate was removed by filtration
through a Celite pad, which was then washed with additional
dichloromethane (2ꢂ50 ml). The solvent was then removed
in vacuo to give an orange/brown oil, which was purified by
column chromatography (hexane/10% ethyl acetate–hex-
ane) to give to give the title compound 12 (199 mg, 83%) as
a colorless oil. IR nmax (film)/cmꢀ1 (neat) 2982, 1714, 1654,
1
1263, 1177, 1096; H NMR (400 MHz; CDCl3) 1.29 (6H,
t, J¼7 Hz), 1.66 (2H, pent, J¼7 Hz), 2.24 (4H, m), 4.20
(4H, q, J¼7 Hz), 5.83 (2H, dd, J¼16, 1 Hz), 6.92 (2H, dt,
J¼16, 7 Hz); 13C NMR (100 MHz; CDCl3) d¼166.5,
148.0, 122.0, 60.2, 31.4, 26.3, 14.3; MS (CI, NH3) m/z 258
(M+NH4)+, 241 (M+H)+; HRMS (CI, NH3) calculated for
C13H21O4 (M+H)+ 241.1434; found (M+H)+ 241.1431.
4.3.6. E,E-Nona-2,7-dienedioic acid ethyl methyl ester
(17). The title compound (94 mg, 70%) was obtained as
a colorless oil. IR nmax (film)/cmꢀ1 (neat) 2984, 1717,
1655, 1368, 1266, 1175, 1097; 1H NMR (400 MHz;
CDCl3) 1.22 (3H, t, J¼7 Hz), 1.57 (2H, pent, J¼7 Hz),
2.15–2.25 (4H, m), 3.66 (3H, s), 4.12 (2H, q, J¼7 Hz),
5.76 (2H, dt, J¼16, 1 Hz), 6.85 (1H, dt, J¼16, 7 Hz), 6.90
(1H, dt, J¼16, 7 Hz); 13C NMR d¼(100 MHz; CDCl3)
167.3, 166.9, 148.8, 148.4, 122.4, 122.0, 60.6, 51.9, 31.8,
31.7, 26.7, 14.7; MS (CI, NH3) m/z 240 (M+NH4)+, 227
(M+H)+; HRMS (CI, NH3) calculated for C12H22O4N
(M+NH4)+ 244.1543; found (M+NH4)+ 244.1547.
1
1368, 1265, 1095; H NMR (400 MHz; CDCl3) 1.28 (6H,
t, J¼7 Hz), 2.35–2.40 (4H, m), 4.18 (4H, q, J¼7 Hz),
5.84 (2H, d, J¼16 Hz), 6.90–6.95 (2H, m); 13C NMR
d¼(100 MHz; CDCl3) 166.7, 147.3, 123.0, 60.7, 30.8,
14.6; MS (CI, NH3) m/z 244 (M+NH4)+, 227 (M+H)+;
HRMS (CI, NH3) calculated for C12H22O4N (M+NH4)+
244.1543; found (M+NH4)+ 244.1542.
Acknowledgements
4.3.2. E,E-2-Methyl-octa-2,6-dienedioic acid diethyl ester
(13). The title compound (351 mg, 73%) was obtained as
a colorless oil. IR nmax (film)/cmꢀ1 (neat) 2982, 1707,
1652, 1367, 1259, 1094; 1H NMR (400 MHz; CDCl3) 1.19
(6H, t, J¼7 Hz), 1.75 (3H, s), 2.20–2.30 (4H, m), 4.10
(4H, q, J¼7 Hz), 5.76 (1H, d, J¼16 Hz), 6.60–6.65 (1H,
m) 6.85–6.95 (1H, m); 13C NMR d¼(100 MHz; CDCl3)
These studies have enjoyed generous financial support
from the Engineering and Physical Sciences Research
Council (D.J.P) and Pfizer Global Research and Develop-
ment, Sandwich (K.S.P). The authors thank the EPSRC
National Mass Spectrometry Service, University of Wales
Swansea, UK.